BSESANDU PHARMACEUTICALS LTD.CriticalNegative
Announced Sat, 11 Jul · 17:29 IST

MD passes away; Balram Viswanathan named new Chairman & MD

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹41.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.2+0.0-3.4-1.5+0.0
Up moveDown movePending
AI summary

Board noted the demise of Managing Director Shri Umesh B. Sandu, who passed away on 19 June 2026. Dr. Neeti Madan Kapre was appointed as Additional Non-Executive Independent Director for 5 years from 11 July 2026. Shri Balram Viswanathan was redesignated from Chairman and Non-Executive Independent Director to Chairman and Managing Director for 3 years, subject to shareholder approval. Board committees were reconstituted and the Vigil Mechanism Policy was updated.

Likely market impact

Leadership transition after the sudden loss of the Managing Director may cause short-term uncertainty; experienced insider takes over as CMD to maintain continuity.